647014-45-7

Basic information

• Product Name: 4-(2-Bromo-4-fluorophenoxy)piperidinehydrochloride
• Synonyms: 4-(2-Bromo-4-fluorophenoxy)piperidinehydrochloride
• CAS NO: 647014-45-7
• Molecular Formula: C₁₁H₁₃BrFNO
• Molecular Weight: 310.5903632
• Mol File: 647014-45-7.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 336.5±42.0 °C(Predicted)
• Appearance: /
• Density: 1.425±0.06 g/cm3(Predicted)
• PKA: 9.61±0.10(Predicted)
• CAS DataBase Reference: 4-(2-Bromo-4-fluorophenoxy)piperidinehydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(2-Bromo-4-fluorophenoxy)piperidinehydrochloride(647014-45-7)
• EPA Substance Registry System: 4-(2-Bromo-4-fluorophenoxy)piperidinehydrochloride(647014-45-7)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 647014-45-7(Hazardous Substances Data)

Usage

Chemical compound

4-(2-Bromo-4-fluorophenoxy)piperidinehydrochloride

Structure

Consists of a piperidine ring with a bromine and fluorine substituted phenoxyl group attached

Form

Present in the form of a hydrochloride salt

Stability

More stable and suitable for pharmaceutical applications

Uses

Often used in the synthesis of drugs and pharmaceutical products

Therapeutic properties

Potential therapeutic properties for pharmaceutical applications

Handling

It is essential to handle this chemical with caution and follow strict safety protocols when working with it in a laboratory setting

Upstream product

• 647014-44-6 tert-butyl 4-(2-bromo-4-fluorophenoxy)piperidine-1-carboxylate 

Downstream Products

• 647014-46-8 4-(2-bromo-4-fluorophenoxy)-1-(methylsulphonyl)piperidine 
• 647014-63-9 tert-butyl (R/S)-3-{[4-(2-bromo-4-fluorophenoxy)piperidin-1-yl]sulphonyl}-2-cyclopentylpropanoate 

Relevant articles and documents

SULPHONYLPIPERIDINE DERIVATIVES CONTAINING AN ARYL OR HETEROARYL GROUP FOR USE AS MATRIX METALLOPROTEINASE INHIBITORS

A compound of formula (1), wherein B is an ortho substituted monocyclic aryl or heteroaryl group or a bicyclic aryl or heteroaryl group; useful in the inhibition of one or more metalloproteinases, and in particular TACE.